Bunaprolast

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameBunaprolast

Drug Alias Name布那司特U-66858

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionArachidonate 5-lipoxygenase inhibitors

TargetsArachidonate 5-lipoxygenase

Therapy Area/IndicationsHypersensitivityAsthma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsHypersensitivityAsthma

ATC CodeN/A